• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内超声成像过程中导丝上的体内血栓形成:肝素化不足的证据。

In vivo thrombus formation on a guidewire during intravascular ultrasound imaging: evidence for inadequate heparinization.

作者信息

Grayburn P A, Willard J E, Brickner M E, Eichhorn E J

机构信息

Department of Internal Medicine, (Cardiology Division), Veteran's Affairs Medical Center, Dallas, Texas 75216.

出版信息

Cathet Cardiovasc Diagn. 1991 Jun;23(2):141-3. doi: 10.1002/ccd.1810230219.

DOI:10.1002/ccd.1810230219
PMID:2070404
Abstract

We present a case in which thrombus formation on a guidewire was visualized during intravascular ultrasound imaging despite the administration of 10,000 units of heparin sulfate prior to the procedure. Gross thrombus formation was confirmed upon removal of the guidewire. The activated clotting time was found to be 191 s, suggesting heparin resistance. This report graphically illustrates the potential thrombogenicity associated with intravascular guidewire manipulation during procedures such as intravascular ultrasound imaging and percutaneous transluminal coronary angioplasty. Moreover, this case suggests that adequate heparinization should be routinely verified by measuring the activated clotting time prior to introducing a guidewire into the arterial system.

摘要

我们报告了一例在血管内超声成像过程中,尽管在操作前给予了10000单位硫酸肝素,但仍在导丝上观察到血栓形成的病例。取出导丝后证实有明显的血栓形成。活化凝血时间为191秒,提示肝素抵抗。本报告以图示说明了在血管内超声成像和经皮腔内冠状动脉成形术等操作过程中,与血管内导丝操作相关的潜在血栓形成风险。此外,该病例表明,在将导丝引入动脉系统之前,应常规通过测量活化凝血时间来验证是否有足够的肝素化。

相似文献

1
In vivo thrombus formation on a guidewire during intravascular ultrasound imaging: evidence for inadequate heparinization.血管内超声成像过程中导丝上的体内血栓形成:肝素化不足的证据。
Cathet Cardiovasc Diagn. 1991 Jun;23(2):141-3. doi: 10.1002/ccd.1810230219.
2
The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children.肝素化在预防儿童经皮心脏导管插入术后动脉血栓形成中的应用。
Circulation. 1974 Sep;50(3):565-9. doi: 10.1161/01.cir.50.3.565.
3
Adequate heparinization during PTCA: assessment using activated clotting times.经皮冠状动脉腔内血管成形术期间充分肝素化:使用活化凝血时间进行评估。
Cathet Cardiovasc Diagn. 1989 Dec;18(4):206-9. doi: 10.1002/ccd.1810180403.
4
In vivo thrombogenicity of intravascular ultrasound imaging catheters.血管内超声成像导管的体内血栓形成性
Acta Radiol. 1995 May;36(3):280-3. doi: 10.1177/028418519503600314.
5
Effect of intraarterial injection of heparin on the complications of percutaneous arterial catheterization in infants and children.
Cathet Cardiovasc Diagn. 1981;7(3):235-46. doi: 10.1002/ccd.1810070303.
6
Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization.肝素化预防小儿经皮动脉导管插入术后血栓形成
Pediatr Cardiol. 1982;3(2):175-80. doi: 10.1007/BF02312966.
7
Letter: Heparin and arterial thrombosis in children.信函:儿童肝素与动脉血栓形成
Circulation. 1975 Jun;51(6):1173-4. doi: 10.1161/01.cir.51.6.1173.
8
Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.小儿心导管术期间凝血酶的形成和未分级肝素的作用。
Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1174-9. doi: 10.1002/ccd.24621. Epub 2013 Feb 26.
9
Arterial complications following cardiac catheterization in children less than 10 kg.体重小于10公斤儿童心脏导管插入术后的动脉并发症
Asian Cardiovasc Thorac Ann. 2002 Jun;10(2):129-32. doi: 10.1177/021849230201000208.
10
Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages.随机接受两种肝素剂量的婴幼儿诊断性心导管插入术后动脉血栓形成的预测因素。
Cathet Cardiovasc Diagn. 1997 Aug;41(4):400-3. doi: 10.1002/(sici)1097-0304(199708)41:4<400::aid-ccd11>3.0.co;2-p.

引用本文的文献

1
Fatal Ovarian Hemorrhage Associated With Anticoagulation Therapy in a Yucatan Mini-Pig Following Venous Stent Implantation.尤卡坦小型猪静脉支架植入术后抗凝治疗相关的致命性卵巢出血
Front Vet Sci. 2020 Jan 30;7:18. doi: 10.3389/fvets.2020.00018. eCollection 2020.
2
Thrombotic Occlusion during Intravascular Ultrasonography-Guided Percutaneous Coronary Intervention of Stumpless Chronic Total Occlusion.血管内超声引导下无残端慢性完全闭塞病变经皮冠状动脉介入治疗期间的血栓性闭塞
Chonnam Med J. 2014 Dec;50(3):112-4. doi: 10.4068/cmj.2014.50.3.112. Epub 2014 Dec 17.
3
Heparin in interventional radiology: a therapy in evolution.
介入放射学中的肝素:一种不断发展的疗法。
Semin Intervent Radiol. 2005 Jun;22(2):95-107. doi: 10.1055/s-2005-871864.
4
Efficacy of enoxaparin, certoparin and dalteparin in preventing cardiac catheter thrombosis: an in vitro approach.依诺肝素、克赛肝素和达肝素预防心导管血栓形成的疗效:体外方法。
J Thromb Thrombolysis. 2010 Apr;29(3):265-70. doi: 10.1007/s11239-009-0355-x.
5
Heparin dose during percutaneous coronary intervention: how low dare we go?经皮冠状动脉介入治疗期间的肝素剂量:我们敢降至多低?
Heart. 2002 Oct;88(4):331-4. doi: 10.1136/heart.88.4.331.
6
Low molecular weight heparin therapy for percutaneous coronary intervention: a practice in evolution.
J Thromb Thrombolysis. 2001 May;11(3):235-46. doi: 10.1023/a:1011917021686.
7
Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.
J Thromb Thrombolysis. 2000 Feb;9(2):163-74. doi: 10.1023/a:1018775015882.
8
Use of the activated clotting time in anticoagulation monitoring of intravascular procedures.活化凝血时间在血管内操作抗凝监测中的应用。
Tex Heart Inst J. 1993;20(4):258-63.